(EKKAPON/AdobeStock)
In
The Emperor of All Maladies, author and oncologist Siddhartha Mukherjee observes that few diseases strike fear into modern man like cancer. Billions of dollars spent on prolific research initiatives have only seen cancer rates rise, without significant progress in the efficacy of cancer treatments.
Enter cannabis. Plentiful preclinical research suggests that specific cannabinoids, such as CBD, may have anticancer and tumor-inhibiting properties.
But, how does that research translate from the test tube to the human body, an infinitely more complex, dynamic environment?
An October 2020 review from a team of researchers in Bulgaria has summarized the anticancer effects of CBD and laid out a tentative map of the ways CBD could enhance or support conventional cancer treatments.